Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 20 studies | 32% ± 9% | |
classical monocyte | 14 studies | 24% ± 11% | |
macrophage | 12 studies | 46% ± 21% | |
monocyte | 10 studies | 26% ± 9% | |
conventional dendritic cell | 10 studies | 30% ± 13% | |
alveolar macrophage | 8 studies | 68% ± 24% | |
epithelial cell | 8 studies | 30% ± 9% | |
type II pneumocyte | 7 studies | 28% ± 12% | |
epithelial cell of proximal tubule | 7 studies | 41% ± 21% | |
enterocyte | 6 studies | 44% ± 14% | |
myeloid cell | 6 studies | 31% ± 9% | |
respiratory goblet cell | 5 studies | 27% ± 7% | |
hepatocyte | 5 studies | 62% ± 18% | |
dendritic cell | 5 studies | 30% ± 17% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1355.81 | 328 / 328 | 93% | 71.66 | 166 / 178 |
liver | 100% | 22468.24 | 226 / 226 | 90% | 159.13 | 365 / 406 |
prostate | 92% | 1077.33 | 226 / 245 | 96% | 98.39 | 482 / 502 |
breast | 96% | 1792.56 | 439 / 459 | 87% | 93.41 | 968 / 1118 |
lung | 100% | 6648.99 | 577 / 578 | 82% | 64.04 | 945 / 1155 |
thymus | 99% | 1109.77 | 646 / 653 | 80% | 36.58 | 487 / 605 |
stomach | 83% | 2837.71 | 298 / 359 | 94% | 66.22 | 269 / 286 |
kidney | 100% | 8111.82 | 89 / 89 | 75% | 36.71 | 673 / 901 |
intestine | 76% | 2001.76 | 732 / 966 | 93% | 56.06 | 492 / 527 |
bladder | 86% | 4304.62 | 18 / 21 | 79% | 71.76 | 396 / 504 |
adrenal gland | 100% | 1771.28 | 258 / 258 | 8% | 1.64 | 18 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.33 | 1 / 1 |
spleen | 94% | 784.32 | 226 / 241 | 0% | 0 | 0 / 0 |
adipose | 89% | 849.89 | 1070 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 1294.28 | 755 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 63.17 | 21 / 29 |
esophagus | 16% | 58.51 | 230 / 1445 | 55% | 33.42 | 100 / 183 |
ovary | 4% | 17.74 | 8 / 180 | 47% | 13.87 | 203 / 430 |
skin | 28% | 221.76 | 503 / 1809 | 21% | 6.45 | 101 / 472 |
uterus | 6% | 29.08 | 11 / 170 | 38% | 18.17 | 175 / 459 |
tonsil | 0% | 0 | 0 / 0 | 29% | 18.47 | 13 / 45 |
blood vessel | 27% | 150.12 | 363 / 1335 | 0% | 0 | 0 / 0 |
brain | 3% | 12.01 | 82 / 2642 | 10% | 2.50 | 72 / 705 |
heart | 9% | 34.62 | 80 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.44 | 2 / 80 |
muscle | 0% | 1.43 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904628 | Biological process | cellular response to phorbol 13-acetate 12-myristate |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0006000 | Biological process | fructose metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0071286 | Biological process | cellular response to magnesium ion |
GO_0046580 | Biological process | negative regulation of Ras protein signal transduction |
GO_0097403 | Biological process | cellular response to raffinose |
GO_0005986 | Biological process | sucrose biosynthetic process |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0071475 | Biological process | cellular hyperosmotic salinity response |
GO_0031667 | Biological process | response to nutrient levels |
GO_0071320 | Biological process | cellular response to cAMP |
GO_0030388 | Biological process | fructose 1,6-bisphosphate metabolic process |
GO_0071477 | Biological process | cellular hypotonic salinity response |
GO_0006094 | Biological process | gluconeogenesis |
GO_0016311 | Biological process | dephosphorylation |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0048029 | Molecular function | monosaccharide binding |
GO_0016208 | Molecular function | AMP binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0042132 | Molecular function | fructose 1,6-bisphosphate 1-phosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FBP1 |
Protein name | Fructose-1,6-bisphosphatase 1 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase) Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase) fructose-bisphosphatase (EC 3.1.3.11) |
Synonyms | FBP hCG_1640493 |
Description | FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain. . FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain. . FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain. . |
Accessions | ENST00000648117.1 Q5VZC3 ENST00000375326.9 P09467 Q2TU34 ENST00000415431.5 A0A3B3IUC7 ENST00000414122.1 ENST00000682520.1 A0A804HJK9 |